1. 2-Arylbenzothiazoles: Advances in Anti-Cancer and Diagnostic Pharmaceuticals Discovery
- Author
-
E. P. Studentsov, Raisa Krasikova, V. I. Krutikov, A. A. Golovina, D. D. Vaulina, V. V. Orlovskaja, and S. M. Ramsh
- Subjects
Antiproliferative Drugs ,010405 organic chemistry ,Chemistry ,medicine ,Future application ,Cancer ,General Chemistry ,Computational biology ,010402 general chemistry ,medicine.disease ,01 natural sciences ,0104 chemical sciences - Abstract
This review summarizes and analyzes published medicinal chemistry data regarding physiologically active 2-arylbenzothiazoles – a promising class of antiproliferative agents and potential diagnostic agents for Alzheimer’s disease. The data have been examined in the light of SAR approach to the properties of 2-arylbenzothiazoles and substances bioactivation mechanisms using labeled radiopharmaceuticals. The most promising leaders-in-class for which clinical trials have been recommended or conducted have been highlighted. Synthetic methods for the preparation of 2-arylbenzothiazoles as precursors of new-generation drugs have been analyzed in detail. Various methods for the preparation of fluorine-containing 2-arylbenzothiazoles, including synthetic pathway to antiproliferative drugs PMX 610, 5-F 203, and Phortress have been described. 2-Arylbenzothiazoles future application in biology and medicine has been discussed.
- Published
- 2021
- Full Text
- View/download PDF